Search Results - "Shalmi, A."

Increased nuchal translucency, normal karyotype and infant development by Miltoft, C. B., Ekelund, C. K., Hansen, B. M., Lando, A., Petersen, O. B., Skovbo, P., Jørgensen, F. S., Sperling, L., Zingenberg, H., Nikkilä, A., Shalmi, A. C., Stornes, I., Ersbak, V., Tabor, A.

“…Objective To investigate whether chromosomally normal fetuses with a nuchal translucency (NT) ≥ 99th percentile (3.5 mm) in the first trimester have an…”
Get full text

Improved first‐trimester Down syndrome screening performance by lowering the false‐positive rate: a prospective study of 9941 low‐risk women by Wøjdemann, K. R., Shalmi, A. C., Christiansen, M., Larsen, S. O., Sundberg, K., Brocks, V., Bang, J., Nørgaard‐Pedersen, B., Tabor, A.

“…Objective To determine the performance of screening for Down syndrome (DS) and other major chromosomal abnormalities using nuchal translucency (NT), free…”
Get full text

Quality assessment in prospective nuchal translucency screening for Down syndrome by Wøjdemann, K. R., Christiansen, M., Sundberg, K., Larsen, S. O., Shalmi, A., Tabor, A.

“…Objectives To develop and apply a quality control system in a Down syndrome screening study using nuchal translucency as an interventional marker. Methods In a…”
Get full text

First trimester screening for Down syndrome and assisted reproduction: no basis for concern by Wøjdemann, K. R., Larsen, S. O., Shalmi, A., Sundberg, K., Christiansen, M., Tabor, A.

“…In pregnancies obtained after assisted reproduction the false‐positive rate of second trimester Down syndrome (DS) screening is increased by 1.5–3‐fold. This…”
Get full text

P13.07: Comparison of last menstrual period and crown‐rump length in gestational dating—the effect of fetal gender, maternal smoking and maternal height by Rode, L., Wøjdemann, K. R., Pedersen, N. G., Sundberg, K., Shalmi, A. C., Christiansen, M., Tabor, A.

Get full text

P13.04: Effect of fetal gender, maternal smoking and maternal height on crown‐rump length by Rode, L., Wøjdemann, K. R., Pedersen, N. G., Sundberg, K., Shalmi, A. C., Christiansen, M., Tabor, A.

Get full text

First trimester Down syndrome screening: Distribution of markers and comparison of assays for quantification of pregnancy-associated plasma protein-A by Wøjdemann, K. R., Larsen, S. O., Rode, L., Shalmi, A., Sundberg, K., Christiansen, M., Tabor, A.

“…Objective. First trimester screening for fetal chromosomal disease is now possible using the maternal serological markers pregnancy-associated plasma protein-A…”
Get full text

Risk of fetal loss associated with invasive testing following combined first‐trimester screening for Down syndrome: a national cohort of 147 987 singleton pregnancies by Wulff, C. B., Gerds, T. A., Rode, L., Ekelund, C. K., Petersen, O. B., Tabor, A., Zingenberg, H., Jørgensen, F. S., Sundberg, K., Shalmi, A. ‐C., Näslund Thagaard, I., Skibsted, L., Fabricius, M., Sperling, L., Mogensen, H., Ibsen, M., Brendstrup, L., Petersen, O. B., Jensen, H. S., Kamper, C. H., Vase, L., Østergaard, M., Sørensen, A., Størup, B.

“…ABSTRACT Objective To assess prospectively the risk of fetal loss associated with chorionic villus sampling (CVS) and amniocentesis (AC) following combined…”
Get full text

OP06.07: Adiponectin in first trimester of pregnancies that later develop preeclampsia: relation to prognosis and adipokines by Christiansen, M., Hedley, P. L., Gjerris, A., Placing, S., Wøjdemann, K., Rode, L., Shalmi, A. C., Sundberg, K., Tabor, A.

Get full text

OC02.03: Increased nuchal translucency, normal karyotype and infant development by Miltoft, C. B., Ekelund, C. K., Hansen, B. M., Lando, A., Petersen, O. B., Skovbo, P., Jørgensen, F. S., Sperling, L., Zingenberg, H., Nikkila, A., Shalmi, A. C., Stornes, I., Ersbak, V., Tabor, A.

Get full text

OC01.04: Perinatal outcome after first trimester risk assessment in monochorionic and dichorionic twin pregnancies: a Danish national database study by Kristiansen, M. K., Christensen, B., Jensen, H. S., Hoseth, E., Farlie, R., Stornes, I., Sommer, S., Juul, S. V., Poulsen, H., Mohapeloa, H., Sperling, L., Pouplier, S., Larsen, T., Shalmi, A., Skibsted, L., Zingenberg, H., Jørgensen, F. S., Ekelund, C. K., Sandager, P., Petersen, O. B.

Get full text

P11.01: Development and establishment of a national Danish fetal medicine database for quality surveillance and research by Ekelund, C. K., Skovbo, P., Holmskov, A., Farlie, R., Stornes, I., Petersen, O. B., Ersbak, V., Sommer, S., Vemmelund, S., Poulsen, H., Mogensen, H., Henriques, C., Andersen, H. J., Larsen, T., Skibsted, L., Kristiansen, A., Shalmi, A. C., Nikkilä, A., Sperling, L., Zingenberg, H., Jørgensen, F. Stener, Tabor, A.

Get full text

P11.01: Development and establishment of a national Danish fetal medicine database for quality surveillance and research: Poster abstracts by Ekelund, C. K., Skovbo, P., Holmskov, A., Farlie, R., Stornes, I., Petersen, O. B., Ersbak, V., Sommer, S., Vemmelund, S., Poulsen, H., Mogensen, H., Henriques, C., Andersen, H. J., Larsen, T., Skibsted, L., Kristiansen, A., Shalmi, A. C., Nikkilä, A., Sperling, L., Zingenberg, H., Jørgensen, F. Stener, Tabor, A.

Get full text

OC044: Outcome of foetuses with enlarged nuchal translucency in the first trimester. Results from the “Copenhagen first trimester study” by Shalmi, A. C., Wøjdemann, K., Sundberg, K., Brocks, V., Christiansen, M., Tabor, A.

Get full text

OC214: Ultrasound screening for severe heart malformation in early pregnancy. A prospective study of 9917 fetuses in a low risk population by Brocks, V., Shalmi, A. C., Sundberg, K., Wøjdemann, K., Tabor, A., Bang, J.

Get full text

OC021: Is “First glance” abnormal nuchal translucency an indication for invasive testing? A prospective evaluation of 9941 women referred for early Down syndrome screening by NT measurement by Sundberg, K., Shalmi, A. C., Howald, L., Tabor, A., Brocks, V., Christiansen, M., Wøjdemann, K.

Get full text

OC226: Combined screening for Down's syndrome in 221 twin pregnancies from the copenhagen first trimester study by Wøjdemann, K., Christiansen, M., Shalmi, A. C., Sundberg, K., Larsen, S. O., Tabor, A.

Get full text

Quality assessment in prospective nuchal translucency screening for Down syndrome in the Copenhagen first trimester study by Wojdemann, K., Christiansen, M., Sundberg, K., Shalmi, A.‐C., Tabor, A.

“…Purpose:  To develop and apply a quality control system in a Down syndrome (DS) screening study using nuchal translucency (NT) as interventional marker…”
Get full text

Reduction of the disintegrin and metalloprotease ADAM12 in preeclampsia by LAIGAARD, Jennie, SORENSEN, Tina, OTTESEN, Bent, CHRISTIANSEN, Michael, WEWER, Ulla M, PLACING, Sophie, HOLCK, Peter, FROHLICH, Camilla, WØJDEMANN, Karen R, SUNDBERG, Karin, SHALMI, Anne-Cathrine, TABOR, Ann, NØRGAARD-PEDERSEN, Bent

“…The secreted form of ADAM12 is a metalloprotease that may be involved in placental and fetal growth. We examined whether the concentration of ADAM12 in…”
Get full text

OC048: First trimester screening for fetal anomalies using ultrasonography in an unselected population. Results from “The Copenhagen First Trimester Study” by Shalmi, A. C., Wøjdemann, K., Sundberg, K., Brocks, V., Græm, N., Tabor, A., Bang, J.

Get full text